Konig et al. [74] reported that in a study of 29 patients with Luminal A breast cancer, cells expressing HER-2 were detected in 68% of patients while 76% of cancer cells expressed Ki-67 in bone marrow aspirates. Here, ERBB2 is linked to breast carcinoma.